Grabarek, B., Krzaczyński, J., Strzałka‐Mrozik, B., Wcisło‐Dziadecka, D., & Gola, J. (2019). The influence of ustekinumab on expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in patients with psoriasis and in a control. Dermatologic therapy, 32(5), e13029-n/a. https://doi.org/10.1111/dth.13029
Citace podle Chicago (17th ed.)Grabarek, Beniamin, Jakub Krzaczyński, Barbara Strzałka‐Mrozik, Dominika Wcisło‐Dziadecka, a Joanna Gola. "The Influence of Ustekinumab on Expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in Patients with Psoriasis and in a Control." Dermatologic Therapy 32, no. 5 (2019): e13029-n/a. https://doi.org/10.1111/dth.13029.
Citace podle MLA (9th ed.)Grabarek, Beniamin, et al. "The Influence of Ustekinumab on Expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in Patients with Psoriasis and in a Control." Dermatologic Therapy, vol. 32, no. 5, 2019, pp. e13029-n/a, https://doi.org/10.1111/dth.13029.